| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-08 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
8e-06 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0007 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |